Robin Fastenau is Metabolon's vice president of Corporate Communications and Investor Relations. She joined Metabolon Inc. in 2014 and oversees its strategic communications, investor relations, and corporate branding. She has held a number of senior-level communications positions within the healthcare industry, including Affordable Care Inc., GlaxoSmithKline, Trimeris, and Triangle Pharmaceuticals (now Gilead Sciences), as well as consulting engagements. Prior to her communications roles, Robin was a vice president in the corporate finance team at an investment banking firm specializing in financial institution clients.
Robin earned a BS in Business Administration with an Economics concentration from Meredith College and holds an MBA from Wake Forest University. She also completed graduate-level Life Sciences course work in the DDS program at the University of North Carolina at Chapel Hill.